Awarded
Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025
£105,600
United Lincolnshire Teaching Hospitals NHS TrustBayer Public Limited Company
goods
Contract Details
- Tender Value
- £105,600
- Stage
- Awarded
- Published
- Awarded
Timeline
Start
Awarded
Disclosed
End
Description
Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo. Additional information: Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.
Related Contracts
From This Buyer
- AHP Agency - Hard to Fill Roles - PSL
£250,000 ·
- Organisational Productivity Interim Support
£810,000 ·
- Acute Floor - Structural Engineer
£60,000 ·
- Acute Floor - M&E
£70,000 ·
From This Supplier
- Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo)
£105,600 ·
- Radiology Contrast Media
£160,100 ·
- Maintenance of Arterion x2
£6,914 ·
In This Category
- IT Peripherals Managed Catalogue
£950,000 ·
- SITS Student Record System Support and Maintenance
£232,145 ·
- SITS Student Record System Support and Maintenance
£304,198 ·
- Large Broadcast Video Camera Order
£45,147 ·
Ref: c397dcd8-b934-47c9-bcb4-13ac11e4bfd7-820308 · Sourced from Contracts Finder
View source notice